drugset / Trial / NCT03325322
Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease
RandomizedParallel-groupTriple-blindTreatment
Summary
The proposed studies will examine the effect of fisetin on adipose tissue-derived mesenchymal stem/stromal cell function, kidney function, markers of inflammation, and physical function in individuals with advanced chronic kidney disease.
Timeline
- Start
- 2018-01-02
- Primary completion
- 2027-01
- Completion
- 2027-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fisetin | Small molecule | 20 mg/kg | Oral |